JG
JAZZ icon

Jefferies Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jefferies Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$2.14M – 1673
2020
Q3 		$2.14M Buy
+15,000
New +$1.86M 0.02% 544
2014
Q4 		– Sell
-20,000
Closed -$3.21M – 2149
2014
Q3 		$3.21M Buy
20,000
+5,000
+33% +$769K 0.02% 560
2014
Q2 		$2.21M Hold
15,000
– – 0.02% 601
2014
Q1 		$2.08M Buy
+15,000
New +$2.26M 0.02% 594

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group's JAZZ Position: Q1 2022 in Review

Jefferies Group sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2022, closing a stake of 2,781 shares — an estimated $354K sold.

Jefferies Group first reported a position in JAZZ in Q2 2013 and held it in 27 quarters. The position peaked at $7.02M in Q3 2015. 461 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

  • Jefferies Group reported no remaining Jazz Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 2,781 Jazz Pharmaceuticals shares in Q1 2022, an estimated $354K.
  • Jefferies Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 27 quarters.
  • Jefferies Group's Jazz Pharmaceuticals position peaked at $7.02M in Q3 2015.
  • 461 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.